* Will present positive data from Phase 2 dose-finding
clinical study of TNX-102 SL for treatment of military-related
PTSD
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom:…
The post BRIEF-Tonix to present data from Phase 2 clinical study of TNX-102 SL appeared first on NASDAQ.